Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 28;15(2):e0229828.
doi: 10.1371/journal.pone.0229828. eCollection 2020.

Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department

Affiliations

Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department

Olivier Peyrony et al. PLoS One. .

Abstract

Introduction: The benefit of reducing the time of antibiotic initiation in the emergency department (ED) for neutropenic patients is controversial and the research on the impact of antibiotic adherence to international guidelines in the ED is scarce. We aimed to investigate the effect of antibiotic timing and appropriateness on outcomes in patients with febrile neutropenia (FN) and to assess the performance of the MASCC risk-index to risk-stratify such patients in the ED.

Methods: We prospectively identified patients with FN who presented to our ED and assessed their Multinational Association of Supportive Care in Cancer (MASCC) risk-index. The time to parenteral antibiotic initiation and the appropriateness of the antibiotic regimen according to international guidelines were retrospectively abstracted. The performance of the MASCC risk-index in predicting the absence of complication was assessed with sensitivity, specificity and the area under the receiver operating characteristics curve (AUC). We investigated the effect of the time to antibiotic initiation and the appropriateness of the antibiotic regimen on the outcome (ICU admission or death) by logistic regression analyses.

Results: We included 249 patients. Median age was 60 years and 67.9% had hematological malignancies, 26 (10.4%) were admitted to the ICU and 23 (9.8%) died during hospital stay. Among the 173 patients at low risk according to the MASCC risk-index, 56 (32.4%) presented at least one complication including 11 deaths. The MASCC risk-index had a sensitivity and a specificity of 0.78% and 0.43%, respectively, in predicting the absence of complication and the AUC was 0.67. The time to antibiotic initiation in the ED was not associated with the outcome after adjusting for performance status and shock-index. Conversely, an inadequate ED antibiotic regimen was associated with higher ICU admission or death during hospital stay (OR = 3.50; 95% CI = 1.49 to 8.28).

Conclusion: An inadequate ED antibiotic regimen in patients with FN was significantly associated with higher ICU admission or death during hospital stay.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Receiver operating characteristics curve.
Accuracy of the MASCC risk-index in predicting the absence of complication for neutropenic patients in the ED. Specificity and sensitivity are indicated for each threshold. AUC area under the curve, MASCC Multinational Association of Supportive Care in Cancer.
Fig 2
Fig 2. Boxplot.
Time to antibiotics initiation in the ED depending on the outcome (ICU or death during hospital stay). Median and IQR were 92 [48–150] min for those who did not meet the outcome and 66 [30–135] min for those who did with no statistical difference according to the Wilcoxon Mann Whitney test (p = 0.097).
Fig 3
Fig 3. Kaplan-Meier curves of the ICU free survival during 90 days from ED presentation depending on the appropriateness of the antibiotic regimen initiated in the ED.

Similar articles

Cited by

References

    1. Brown J, Grudzen C, Kyriacou DN, Obermeyer Z, Quest T, Rivera D, et al. The Emergency Care of Patients with Cancer: Setting the Research Agenda. Ann Emerg Med 2016;68:706–11. 10.1016/j.annemergmed.2016.01.021 - DOI - PMC - PubMed
    1. Sammut SJ, Mazhar D. Management of febrile neutropenia in an acute oncology service. QJM 2012;105:327–36. 10.1093/qjmed/hcr217 - DOI - PubMed
    1. Perron T, Emara M, Ahmed S. Time to antibiotics and outcomes in cancer patients with febrile neutropenia. BMC Health Serv Res 2014;14:162 10.1186/1472-6963-14-162 - DOI - PMC - PubMed
    1. Lynn JJ, Chen KF, Weng YM, Chiu TF. Risk factors associated with complications in patientswith chemotherapy-induced febrile neutropenia in emergency department. Hematol Oncol 2013;31:189–96. 10.1002/hon.2040 - DOI - PubMed
    1. Keng MK, Thallner EA, Elson P, Ajon C, Sekeres J, Wenzell CM, et al. Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department. J Oncol Pract 2015;11:450–5. 10.1200/JOP.2014.002733 - DOI - PubMed

Substances